Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Ophthalmol Glaucoma. 2020 Aug 15;4(1):5–9. doi: 10.1016/j.ogla.2020.08.006

Using clinical decision support systems to bring predictive models to the glaucoma clinic

Brian C Stagg 1,2, Joshua D Stein 3,4,5, Felipe A Medeiros 6, Barbara Wirostko 1, Alan Crandall 1, M Elizabeth Hartnett 1, Mollie Cummins 7, Alan Morris 8, Rachel Hess 2,9, Kensaku Kawamoto 10
PMCID: PMC7854795  NIHMSID: NIHMS1622768  PMID: 32810611

Abstract

Advances in the field of predictive modeling using artificial intelligence and machine learning have the potential to improve clinical care and outcomes, but only if the results of these models are appropriately presented to clinicians at the time they make decisions for individual patients. Clinical decision support (CDS) systems could be used to accomplish this. Modern CDS systems are computer-based tools designed to improve clinician decision making for individual patients. However, not all CDS systems are effective. Four principles that have been shown in other medical fields to be important for successful CDS system implementation are (1) integration into clinician workflow, (2) user-centered interface design, (3) evaluation of CDS systems and rules, and (4) standards-based development so the tools can be deployed across health systems.

Introduction

Clinicians today are faced with the challenging task of incorporating large amounts of data accurately and efficiently to make critical decisions that impact patient health.1 Clinicians who care for patients with glaucoma are faced daily with this challenge; caring for glaucoma requires synthesis of information from many data sources (tonometry, pachymetry, perimetry, optical coherence tomography, disc photographs, ocular exam, patient history, etc.) from many visits over long time periods.2 These data are often complex and have high test-retest variability.3 The data must be interpreted in the context of patient-specific circumstances.2 Adding to the challenge, the data need to be evaluated and integrated quickly to make a decision in the midst of a busy glaucoma clinic. Recent advances in the field of predictive modeling may help address some of these challenges.4

Predictive modeling in health care involves the analysis of retrospective healthcare data to estimate the future likelihood of an event for a specific patient.5 Predictive modeling for glaucoma has been conducted using traditional statistical methods (for example, linear regression,68 logistic regression,6,8,9 and Cox proportional hazards models10,11) and using more sophisticated artificial intelligence (AI) methods, including machine learning methods such as neural networks and deep learning using deep neural networks.1225 However, these predictive models have not yet substantially influenced glaucoma clinical practice in part because calculating a prediction is not, in itself, sufficient to influence clinician behavior.4 For the results of glaucoma predictive models to meaningfully improve clinical practice, clinically useful information from the models must be presented to the decision maker in an effective format at the optimal time in the clinical workflow to facilitate sound decisions.26 Clinical decision support (CDS) systems can help address these challenges.26,27

Modern CDS systems are computer-based tools designed to improve clinician decision making for individual patients.27,28 These systems have been successfully employed for many non-ocular conditions, including diabetes,29 cancer,30 sepsis,31 acute respiratory distress syndrome,32 hyperglycemia,33 and neonatal hyperbilirubinemia.34 CDS systems can improve diagnostic test use35 and treatment decisions.3638 An illustrative example of a successful CDS system is an electronic health record (EHR) add-on app for neonatal bilirubin management.34 Similar to glaucoma care, clinicians managing neonatal bilirubin levels must retrieve data that is scattered across the medical record, synthesize the data, and apply guideline algorithms to develop patient-specific treatment plans. The CDS tool gathered the data into one display and provided guideline-based individualized treatment recommendations.

While there has been a considerable amount of research regarding CDS in other medical fields, relatively little work has been done in ophthalmology and glaucoma. This may be because ophthalmology adopted EHRs later than many other medical fields.39 The use of EHRs in ophthalmology has increased dramatically.40 This, coupled with advances in predictive modeling for glaucoma, provides an opportunity for us to develop effective CDS for glaucoma. As we do this, we can learn from CDS successes and failures from other medical fields.41 A considerable body of literature has evaluated characteristics that are important for the success of CDS systems.4244 Four principles that have been shown in other medical fields to be important for successful CDS system implementation are (1) integration into clinician workflow, (2) user-centered interface design, (3) evaluation of CDS systems and rules, and (4) standards-based development so the tools can be deployed across health systems.4244 The purpose of this paper is to describe these important CDS system principles and to discuss how they could be applied to glaucoma to allow us to develop CDS systems that leverage advances in glaucoma predictive modeling to improve clinical care.

Integration into Clinician Workflow

CDS systems need to be designed to facilitate implementation and integration into clinical workflow.45,46 Integration into clinical workflow means that the decision support is provided at the time the decision is being made to the decision maker in an effective and seamless format.26 Automatic provision of CDS as part of clinician workflow is one of the strongest predictors of whether or not a CDS tool will improve clinical practice.47 Clinicians spend a considerable amount of time using EHRs.48 CDS systems that require significant time and effort add to this burden and are less likely to be used.49 Instead, CDS systems should be designed to fit into clinicians’ routine use of the EHR.50

Studying the clinical context and workflow of decision making and incorporating the results of these studies in the design of CDS tools facilitates implementation and use of CDS.45,51,52 For example, an in-depth analysis of the clinical workflow allowed Weir et al. to successfully implement CDS tools targeting improved geriatric care.52 In this study, researchers engaged users and IT departments to understand their workflow and interaction with the EHR and the CDS system. The CDS interventions were designed and adapted to fit into this workflow.

In the context of glaucoma management, integration into clinician workflow necessitates providing the CDS to the clinician seamlessly when a specific decision is being made. For example, a CDS tool designed to help identify glaucomatous progression would need to be presented to the clinician at the moment in clinical workflow that the clinician is deciding if there has been progression. In the case of glaucoma, additional research is needed to understand the glaucoma clinical workflow and decision-making process. Integration of future CDS systems for glaucoma into the established clinical workflow will make these systems easier to access and use, which will make them more likely to improve glaucoma outcomes.

User-Centered Interface Design

User-centered design focuses on the needs of users to make information systems more usable and involves identifying and understanding the system users, tasks, and environments in which the users perform the tasks.53 The user-centered design process is iterative and involves users throughout the design process.54 Established scientific methods for user-centered design include ethnographic observations, interview analysis, think-aloud studies, cognitive work analysis, and observation of real-time use in the clinical application site.54 Though many methods can be used for user-centered design, some basic principles are (1) understanding the users, tasks, and environments, (2) understanding the usability requirements for the system being developed, (3) designing the system to meet these requirements, and (4) evaluating the design with users.53

User-centered interface design of CDS systems allows effective communication of CDS system recommendations and results.5456 Involving clinicians in the design of CDS tools can increase usability and satisfaction.57 An example of user-centered design for a CDS system is a CDS tool developed to present results of published randomized controlled trials to clinicians at the point of care.57 In this study, Del Fiol et al. used rapid iterative cycles incorporating feedback from physician users of the CDS prototypes. This user-centered design process allowed for the development of a useful and usable CDS tool.

As CDS systems for glaucoma care are developed, it is important that user-centered design principles are followed. User-centered interface design for glaucoma CDS would involve clinicians who care for patients with glaucoma in the design and testing of the CDS interface to ensure that user needs are met and information is communicated effectively. Clinicians who care for patients with glaucoma should be actively involved in the planning, development, and testing of CDS systems designed to improve glaucoma care.

Evaluation of CDS Systems and Rules

CDS systems and rules should be rigorously evaluated.58 CDS rules are the underling predictive models or algorithms that CDS systems use to provide decision support. The most rigorous study design that is feasible should be used to evaluate CDS systems.50 Cluster randomized controlled trials are the preferred method, but if randomization is not feasible an interrupted time series study design may be appropriate.50

It is important that the results of CDS systems are also evaluated as the systems are applied in new populations. One key challenge of CDS is the rules developed in one context may not necessarily apply in another. For example, glaucoma CDS rules developed for an inner-city population at a large academic center may not be appropriate when applied in a private-practice, rural clinic. One way to address this limitation is to retrospectively run the CDS rules on a large set of patients and examine the CDS results against each patient’s EHR data before implementing the CDS system.50

Standards-based Development

CDS tool interoperability means the tool to be used at different sites (with different EHRs).58 Interoperability is one of the key challenges to widespread scaling of CDS.58 Substitutable Medical Applications, Reusable Technologies (SMART) on Fast Healthcare Interoperability Resources (FHIR) (pronounced “smart on fire”) is an interoperable, standards-based platform that can be used for CDS. SMART and FHIR are health informatics standards frameworks developed by the Health Level Seven International (HL7) standards development organization.59 The FHIR standard provides a systematic, interoperable way to define and represent data in EHRs and allows for the exchange of healthcare information electronically. SMART on FHIR is a platform that uses the FHIR standard to enable medical applications to be written once and run unmodified across different healthcare IT systems.60

The use of SMART on FHIR is promoted by the NIH as an important interoperable health informatics tool approach (NOT-OD-19-122).61 The SMART on FHIR platform provides a standard way for CDS systems and other health informatics applications to be integrated with the EHR and has been used for clinical decision support applications.34,62,63 The EHR add-on app for neonatal bilirubin management discussed above is an example of how the SMART on FHIR technology can link to the EHR and provide a scalable, usable approach to integrating CDS in health care.34 Other complementary standards include the HL7 CDS Hooks standard64 which enables alerts and reminders to be integrated with EHRs, as well as the HL7 Clinical Quality Language65 which provides a standard language for expressing rules for CDS and electronic clinical quality measurement.

FHIR already supports a number of data elements that would be useful for glaucoma CDS, such as age, gender, race, medical and ocular diagnoses, medications in use, past medications, past procedures, and visual acuity. For other data elements needed for eye care, the ophthalmology community could work together to advance the inclusion of those data elements in the U.S. Core Data for Interoperability66 which defines the FHIR data elements that must be supported by EHR vendors.67 Developing CDS tools for glaucoma management using a standards-based approach such as SMART on FHIR could enable these tools to provide value to glaucoma specialists across a variety of different practice types using a variety of different EHR systems.

Conclusion

For advances in predictive modeling to meaningfully improve glaucoma care, the results of these models need to be appropriately presented to clinicians at the time they make decisions for individual patients. CDS systems that are coupled with EHRs can accomplish this if these CDS systems are well-integrated into clinician workflow, have usable and understandable interfaces, and are standards-based to enable interoperability. If these CDS systems are developed and implemented appropriately with a focus on user needs, they have the potential to augment clinical decision making, enhance workflow, and improve patient outcomes.

Clinical decision support systems are computer-based tools designed to improve clinician decision making for individual patients. These tools could be used to present the results of glaucoma predictive models to clinicians as they make decisions.

Acknowledgments

Financial Support: This work was supported by National Institutes of Health (R01EY026641 to JDS and EY029885 to FAM) and an Unrestricted Grant from Research to Prevent Blindness, New York, NY, to the Department of Ophthalmology & Visual Sciences, University of Utah. The funding organizations had no role in the design or conduct of this research.

Conflict of Interest: KK reports honoraria, consulting, or sponsored research outside the submitted work with McKesson InterQual, Hitachi, Pfizer, Premier, Klesis Healthcare, RTI International, Mayo Clinic, Vanderbilt University, the University of Washington, the University of California at San Francisco, and the U.S. Office of the National Coordinator for Health IT (via ESAC, JBS International, A+ Government Solutions, Hausam Consulting, and Security Risk Solutions) in the area of health information technology. KK is also an unpaid board member of the non-profit Health Level Seven International health IT standard development organization, and he has helped develop a number of health IT tools which may be commercialized to enable wider impact. None of these relationships have direct relevance to the manuscript but are reported in the interest of full disclosure.

RH reports personal fees from Astellas Pharmaceuticals, outside the submitted work

FAM reports grants from National Eye Institute, during the conduct of the study; personal fees from Aeri Pharmaceuticals, personal fees from Allergan, personal fees from Novartis, personal fees from Biogen, personal fees from Galimedix, personal fees from Annexon, grants from Google, Inc, grants from Carl-Zeiss Meditec, personal fees from Heidelberg Engineering, personal fees from Stealth Biotherapeutics, personal fees from IDx, personal fees from Reichert, outside the submitted work.

BW other conflict of interest from Qualris, outside the submitted work.

The other authors have no conflicts to report.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Meeting Presentation: This work has not been presented at a meeting.

References

  • 1.Obermeyer Z, Emanuel EJ. Predicting the Future — Big Data, Machine Learning, and Clinical Medicine. N Engl J Med. 2016;375(13):1216–1219. doi: 10.1056/NEJMp1606181 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Prum BE, Rosenberg LF, Gedde SJ, et al. Primary Open-Angle Glaucoma Preferred Practice Pattern(®) Guidelines. Ophthalmology. 2016;123(1):P41–P111. doi: 10.1016/j.ophtha.2015.10.053 [DOI] [PubMed] [Google Scholar]
  • 3.Crabb DP, Russell RA, Malik R, et al. Frequency of Visual Field Testing When Monitoring Patients Newly Diagnosed with Glaucoma: Mixed Methods and Modelling. NIHR Journals Library; 2014. Accessed June 10, 2019 http://www.ncbi.nlm.nih.gov/books/NBK259972/ [PubMed] [Google Scholar]
  • 4.Emanuel EJ, Wachter RM. Artificial Intelligence in Health Care: Will the Value Match the Hype? JAMA. 2019;321(23):2281–2282. doi: 10.1001/jama.2019.4914 [DOI] [PubMed] [Google Scholar]
  • 5.Sniderman AD, Sr RBD, Pencina MJ. The Role of Physicians in the Era of Predictive Analytics. JAMA. 2015;314(1):25–26. doi: 10.1001/jama.2015.6177 [DOI] [PubMed] [Google Scholar]
  • 6.De Moraes CG, Sehi M, Greenfield DS, Chung YS, Ritch R, Liebmann JM. A Validated Risk Calculator to Assess Risk and Rate of Visual Field Progression in Treated Glaucoma Patients. Invest Ophthalmol Vis Sci. 2012;53(6):2702–2707. doi: 10.1167/iovs.11-7900 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Leal I, Chu CJ, Yang YY, Manasses DM, Sebastian RT, Sparrow JM. Intraocular Pressure Reduction After Real-world Cataract Surgery. J Glaucoma. 2020;Publish Ahead of Print. doi: 10.1097/IJG.0000000000001527 [DOI] [PubMed] [Google Scholar]
  • 8.Zhang X, Parrish RK, Greenfield DS, et al. Predictive Factors for the Rate of Visual Field Progression in the Advanced Imaging for Glaucoma Study. Am J Ophthalmol. 2019;202:62–71. doi: 10.1016/j.ajo.2019.02.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Baxter SL, Marks C, Kuo T-T, Ohno-Machado L, Weinreb RN. Machine Learning-Based Predictive Modeling of Surgical Intervention in Glaucoma Using Systemic Data From Electronic Health Records. Am J Ophthalmol. 2019;208:30–40. doi: 10.1016/j.ajo.2019.07.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.A Validated Prediction Model for the Development of Primary Open Angle Glaucoma in Individuals with Ocular Hypertension. Ophthalmology. 2007;114(1):10–19. doi: 10.1016/j.ophtha.2006.08.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kurysheva NI, Lepeshkina LV, Shatalova EO. Predictors of Outcome in Selective Laser Trabeculoplasty: A Long-term Observation Study in Primary Angle-closure Glaucoma After Laser Peripheral Iridotomy Compared With Primary Open-angle Glaucoma. J Glaucoma. 2018;27(10):880–886. doi: 10.1097/IJG.0000000000001048 [DOI] [PubMed] [Google Scholar]
  • 12.Murtagh P, Greene G, O’Brien C. Current applications of machine learning in the screening and diagnosis of glaucoma: a systematic review and Meta-analysis. Int J Ophthalmol. 2020;13(1):149–162. doi: 10.18240/ijo.2020.01.22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zheng C, Johnson T, Garg A, Boland M. Artificial intelligence in glaucoma. Curr Opin Ophthalmol. 2019;30(2):97–103. doi: 10.1097/ICU.0000000000000552 [DOI] [PubMed] [Google Scholar]
  • 14.Garcia G-GP, Lavieri MS, Andrews C, et al. Accuracy of Kalman Filtering in Forecasting Visual Field and Intraocular Pressure Trajectory in Patients With Ocular Hypertension. JAMA Ophthalmol. Published online November 14, 2019. doi: 10.1001/jamaophthalmol.2019.4190 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Garcia G-GP, Nitta K, Lavieri MS, et al. Using Kalman Filtering to Forecast Disease Trajectory for Patients With Normal Tension Glaucoma. Am J Ophthalmol. 2019;199:111–119. doi: 10.1016/j.ajo.2018.10.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Jammal AA, Thompson AC, Mariottoni EB, et al. Human Versus Machine: Comparing a Deep Learning Algorithm to Human Gradings for Detecting Glaucoma on Fundus Photographs. Am J Ophthalmol. Published online November 12, 2019. doi: 10.1016/j.ajo.2019.11.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Shigueoka LS, Vasconcellos JPC, de Schimiti RB, et al. Automated algorithms combining structure and function outperform general ophthalmologists in diagnosing glaucoma. PloS One. 2018;13(12):e0207784. doi: 10.1371/journal.pone.0207784 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Christopher M, Belghith A, Weinreb RN, et al. Retinal Nerve Fiber Layer Features Identified by Unsupervised Machine Learning on Optical Coherence Tomography Scans Predict Glaucoma Progression. Invest Ophthalmol Vis Sci. 2018;59(7):2748–2756. doi: 10.1167/iovs.17-23387 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Wang M, Tichelaar J, Pasquale LR, et al. Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence. JAMA Ophthalmol. Published online January 2, 2020. doi: 10.1001/jamaophthalmol.2019.5413 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Rogers TW, Jaccard N, Carbonaro F, et al. Evaluation of an AI system for the automated detection of glaucoma from stereoscopic optic disc photographs: the European Optic Disc Assessment Study. Eye Lond Engl. 2019;33(11):1791–1797. doi: 10.1038/s41433-019-0510-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Sample PA, Boden C, Zhang Z, et al. Unsupervised machine learning with independent component analysis to identify areas of progression in glaucomatous visual fields. Invest Ophthalmol Vis Sci. 2005;46(10):3684–3692. doi: 10.1167/iovs.04-1168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ting DSW, Pasquale LR, Peng L, et al. Artificial intelligence and deep learning in ophthalmology. Br J Ophthalmol. 2019;103(2):167–175. doi: 10.1136/bjophthalmol-2018-313173 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Long E, Wan P, Zhuo Y. Predicting the Real-World Future of Glaucoma Patients? Cautions Are Required for Machine Learning. Transl Vis Sci Technol. 2017;6(6). doi: 10.1167/tvst.6.6.3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Devalla SK, Liang Z, Pham TH, et al. Glaucoma management in the era of artificial intelligence. Br J Ophthalmol. Published online October 22, 2019. doi: 10.1136/bjophthalmol-2019-315016 [DOI] [PubMed] [Google Scholar]
  • 25.Hirasawa H, Murata H, Mayama C, Araie M, Asaoka R. Evaluation of various machine learning methods to predict vision-related quality of life from visual field data and visual acuity in patients with glaucoma. Br J Ophthalmol. 2014;98(9):1230–1235. doi: 10.1136/bjophthalmol-2013-304319 [DOI] [PubMed] [Google Scholar]
  • 26.Sirajuddin AM, Osheroff JA, Sittig DF, Chuo J, Velasco F, Collins DA. Implementation Pearls from a New Guidebook on Improving Medication Use and Outcomes with Clinical Decision Support. J Healthc Inf Manag. 2009;23(4):38–45. [PMC free article] [PubMed] [Google Scholar]
  • 27.Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. Npj Digit Med. 2020;3(1):1–10. doi: 10.1038/s41746-020-0221-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Berner E, ed. Clinical Decision Support Systems: Theory and Practice. 3rd Edition Springer International Publishing; 2016. [Google Scholar]
  • 29.Edholm K, Lappé K, Kukhareva P, et al. Reducing Diabetic Ketoacidosis Intensive Care Unit Admissions Through an Electronic Health Record-Driven, Standardized Care Pathway. J Healthc Qual Off Publ Natl Assoc Healthc Qual. Published online January 9, 2020. doi: 10.1097/JHQ.0000000000000247 [DOI] [Google Scholar]
  • 30.Del Fiol G, Kohlmann W, Bradshaw RL, et al. Standards-Based Clinical Decision Support Platform to Manage Patients Who Meet Guideline-Based Criteria for Genetic Evaluation of Familial Cancer. JCO Clin Cancer Inform. 2020;4:1–9. doi: 10.1200/CCI.19.00120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Stipelman CH, Smith ER, Diaz-Ochu M, et al. Early-Onset Sepsis Risk Calculator Integration Into an Electronic Health Record in the Nursery. Pediatrics. 2019;144(2). doi: 10.1542/peds.2018-3464 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.McKinley BA, Moore FA, Sailors RM, et al. Computerized decision support for mechanical ventilation of trauma induced ARDS: results of a randomized clinical trial. J Trauma. 2001;50(3):415–424; discussion 425. doi: 10.1097/00005373-200103000-00004 [DOI] [PubMed] [Google Scholar]
  • 33.Morris AH, Orme J, Truwit JD, et al. A replicable method for blood glucose control in critically Ill patients. Crit Care Med. 2008;36(6):1787–1795. doi: 10.1097/CCM.0b013e3181743a5a [DOI] [PubMed] [Google Scholar]
  • 34.Kawamoto K, Kukhareva P, Shakib JH, et al. Association of an Electronic Health Record Add-on App for Neonatal Bilirubin Management With Physician Efficiency and Care Quality. JAMA Netw Open. 2019;2(11):e1915343. doi: 10.1001/jamanetworkopen.2019.15343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Goldzweig CL, Orshansky G, Paige NM, et al. Electronic health record-based interventions for improving appropriate diagnostic imaging: a systematic review and meta-analysis. Ann Intern Med. 2015;162(8):557–565. doi: 10.7326/M14-2600 [DOI] [PubMed] [Google Scholar]
  • 36.Page N, Baysari MT, Westbrook JI. A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital CPOE systems to change prescriber behavior and improve patient safety. Int J Med Inf. 2017;105:22–30. doi: 10.1016/j.ijmedinf.2017.05.011 [DOI] [PubMed] [Google Scholar]
  • 37.Curtis CE, Al Bahar F, Marriott JF. The effectiveness of computerised decision support on antibiotic use in hospitals: A systematic review. PloS One. 2017;12(8):e0183062. doi: 10.1371/journal.pone.0183062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Borab ZM, Lanni MA, Tecce MG, Pannucci CJ, Fischer JP. Use of Computerized Clinical Decision Support Systems to Prevent Venous Thromboembolism in Surgical Patients: A Systematic Review and Meta-analysis. JAMA Surg. 2017;152(7):638–645. doi: 10.1001/jamasurg.2017.0131 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Grinspan ZM, Banerjee S, Kaushal R, Kern LM. Physician Specialty and Variations in Adoption of Electronic Health Records. Appl Clin Inform. 2013;4(2):225–240. doi: 10.4338/ACI-2013-02-RA-0015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Lim MC, Boland MV, McCannel CA, et al. Adoption of Electronic Health Records and Perceptions of Financial and Clinical Outcomes Among Ophthalmologists in the United States. JAMA Ophthalmol. 2018;136(2):164–170. doi: 10.1001/jamaophthalmol.2017.5978 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Bright TJ, Wong A, Dhurjati R, et al. Effect of Clinical Decision-Support Systems: A Systematic Review. Ann Intern Med. 2012;157(1):29. doi: 10.7326/0003-4819-157-1-201207030-00450 [DOI] [PubMed] [Google Scholar]
  • 42.Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005;330(7494):765. doi: 10.1136/bmj.38398.500764.8F [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Horsky J, Phansalkar S, Desai A, Bell D, Middleton B. Design of decision support interventions for medication prescribing. Int J Med Inf. 2013;82(6):492–503. doi: 10.1016/j.ijmedinf.2013.02.003 [DOI] [PubMed] [Google Scholar]
  • 44.Kilsdonk E, Peute LW, Jaspers MWM. Factors influencing implementation success of guideline-based clinical decision support systems: A systematic review and gaps analysis. Int J Med Inf. 2017;98:56–64. doi: 10.1016/j.ijmedinf.2016.12.001 [DOI] [PubMed] [Google Scholar]
  • 45.Weir CR, Rubin MA, Nebeker J, Samore M. Modeling the mind: How do we design effective decision-support? J Biomed Inform. 2017;71:S1–S5. doi: 10.1016/j.jbi.2017.06.008 [DOI] [PubMed] [Google Scholar]
  • 46.Elwyn G, Scholl I, Tietbohl C, et al. “Many miles to go …”: a systematic review of the implementation of patient decision support interventions into routine clinical practice. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S14. doi: 10.1186/1472-6947-13-S2-S14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Kawamoto K, Lobach DF. Clinical Decision Support Provided within Physician Order Entry Systems: A Systematic Review of Features Effective for Changing Clinician Behavior. AMIA Annu Symp Proc. 2003;2003:361–365. [PMC free article] [PubMed] [Google Scholar]
  • 48.Tai-Seale M, Olson CW, Li J, et al. Electronic Health Record Logs Indicate That Physicians Split Time Evenly Between Seeing Patients And Desktop Medicine. Health Aff Proj Hope. 2017;36(4):655–662. doi: 10.1377/hlthaff.2016.0811 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Van de Velde S, Heselmans A, Delvaux N, et al. A systematic review of trials evaluating success factors of interventions with computerised clinical decision support. Implement Sci. 2018;13(1):114. doi: 10.1186/s13012-018-0790-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Kawamoto K, McDonald CJ. Designing, Conducting, and Reporting Clinical Decision Support Studies: Recommendations and Call to Action. Ann Intern Med. 2020;172(11_Supplement):S101–S109. doi: 10.7326/M19-0875 [DOI] [PubMed] [Google Scholar]
  • 51.Smith MW, Brown C, Virani SS, et al. Incorporating Guideline Adherence and Practice Implementation Issues into the Design of Decision Support for Beta-Blocker Titration for Heart Failure. Appl Clin Inform. 2018;9(2):478–489. doi: 10.1055/s-0038-1660849 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Weir C, Brunker C, Butler J, Supiano MA. Making cognitive decision support work: Facilitating adoption, knowledge and behavior change through QI. J Biomed Inform. 2017;71:S32–S38. doi: 10.1016/j.jbi.2016.08.020 [DOI] [PubMed] [Google Scholar]
  • 53.User-Centered Design Basics | Usability.gov. Published April 3, 2017. Accessed July 6, 2020 user-centered-design.html
  • 54.Horsky J, Schiff GD, Johnston D, Mercincavage L, Bell D, Middleton B. Interface design principles for usable decision support: A targeted review of best practices for clinical prescribing interventions. J Biomed Inform. 2012;45(6):1202–1216. doi: 10.1016/j.jbi.2012.09.002 [DOI] [PubMed] [Google Scholar]
  • 55.Yen P-Y, Bakken S. Review of health information technology usability study methodologies. J Am Med Inform Assoc JAMIA. 2012;19(3):413–422. doi: 10.1136/amiajnl-2010-000020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Brunner J, Chuang E, Goldzweig C, Cain CL, Sugar C, Yano EM. User-centered design to improve clinical decision support in primary care. Int J Med Inf. 2017;104:56–64. doi: 10.1016/j.ijmedinf.2017.05.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Del Fiol G, Mostafa J, Pu D, et al. Formative evaluation of a patient-specific clinical knowledge summarization tool. Int J Med Inf. 2016;86:126–134. doi: 10.1016/j.ijmedinf.2015.11.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Tcheng JE, National Academy of Medicine (U.S.), eds. Optimizing Strategies for Clinical Decision Support: Summary of a Meeting Series. National Academy of Medicine; 2017. [PubMed] [Google Scholar]
  • 59.Overview - FHIR v4.0.1. Accessed June 29, 2020 https://www.hl7.org/fhir/overview.html
  • 60.Mandel JC, Kreda DA, Mandl KD, Kohane IS, Ramoni RB. SMART on FHIR: a standards-based, interoperable apps platform for electronic health records. J Am Med Inform Assoc JAMIA. 2016;23(5):899–908. doi: 10.1093/jamia/ocv189 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.NOT-OD-19-122: Fast Healthcare Interoperability Resources (FHIR) Standard. Accessed February 20, 2020 https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-122.html
  • 62.Warner JL, Rioth MJ, Mandl KD, et al. SMART precision cancer medicine: a FHIR-based app to provide genomic information at the point of care. J Am Med Inform Assoc JAMIA. 2016;23(4):701–710. doi: 10.1093/jamia/ocw015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Sinha S, Jensen M, Mullin S, Elkin PL. Safe Opioid Prescription: A SMART on FHIR Approach to Clinical Decision Support. Online J Public Health Inform. 2017;9(2):e193. doi: 10.5210/ojphi.v9i2.8034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.1.0 - CDS Hooks. Accessed July 20, 2020 https://cds-hooks.hl7.org/1.0/
  • 65.Clinical Quality Language (CQL). Accessed July 20, 2020 https://cql.hl7.org/
  • 66.United States Core Data for Interoperability (USCDI) | Interoperability Standards Advisory (ISA). Accessed July 20, 2020 https://www.healthit.gov/isa/united-states-core-data-interoperability-uscdi
  • 67.21st Century Cures Act: Interoperability, Information Blocking, and the ONC Health IT Certification Program. Federal Register. Published May 1, 2020. Accessed July 20, 2020 https://www.federalregister.gov/documents/2020/05/01/2020-07419/21st-century-cures-act-interoperability-information-blocking-and-the-onc-health-it-certification

RESOURCES